Ultrasound May Be Appropriate for Women With Focal Noncyclic Breast Pain
Imaging for breast pain is not usually recommended, however, ultrasound may be appropriate for women with focal, noncyclic pain.
Focal noncyclical breast pain is rarely a sign of cancer, however, ultrasound may be an appropriate imaging modality for initial examination, according to an article published in the Journal of the American College of Radiology. A multidisciplinary expert panel annually reviews the American College of Radiology Appropriateness Criteria, evidence-based guidelines for specific clinical conditions, including imaging guidelines for breast cancer screening and diagnosis. The panel reviewed the use of imaging for patients who present with breast pain which, although common, is rarely associated with breast cancer. According to the panel, appropriate workup depends on the nature and focality of the pain, as well as the age of the patient. Imaging evaluation is usually not indicated if the pain is cyclic or nonfocal, while imaging may be appropriate for complaints of focal, noncyclic pain, mainly for reassurance and to identify treatable causes. Ultrasound can be the initial examination used to evaluate women under age 30 with focal, noncyclic breast pain; for women 30 and older, diagnostic mammography, digital breast tomosynthesis, and ultrasound may all serve as appropriate initial examinations. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.
AI-Initiated Recalls After Screening Mammography Demonstrate Higher PPV for Breast Cancer
March 18th 2025While recalls initiated by one of two reviewing radiologists after screening mammography were nearly 10 percent higher than recalls initiated by an AI software, the AI-initiated recalls had an 85 percent higher positive predictive value for breast cancer, according to a new study.
ECR Mammography Study: Pre-Op CEM Detects 34 Percent More Multifocal Masses than Mammography
February 28th 2025In addition to contrast-enhanced mammography (CEM) demonstrating over a 90 percent detection rate for multifocal masses, researchers found that no significant difference between histological measurements and CEM, according to study findings presented at the European Congress of Radiology.
Study: Mammography AI Leads to 29 Percent Increase in Breast Cancer Detection
February 5th 2025Use of the mammography AI software had a nearly equivalent false positive rate as unassisted radiologist interpretation and resulted in a 44 percent reduction in screen reading workload, according to findings from a randomized controlled trial involving over 105,000 women.
